Ketamine Therapy Safety: Risks & What the Evidence Shows

Ketamine infusion therapy has helped many patients with treatment-resistant depression and difficult pain syndromes — and we've seen those results firsthand. But responsible treatment means being just as clear about what remains uncertain as about what works. This page is the honest counterweight to the hope: the questions, cautions, and unknowns that every patient considering ketamine deserves to understand. We'd rather you begin treatment with clear eyes than oversold expectations.

What the evidence supports

Ketamine can produce rapid improvement in mood in a substantial portion of patients with depression that hasn't responded to standard antidepressants — sometimes within hours to days, compared with the weeks conventional antidepressants require. For several difficult pain conditions, it can provide meaningful relief when other approaches have failed. This rapid action is precisely what makes it valuable, and it's why the treatment exists.

What we genuinely don't know

Intellectual honesty requires naming the limits of the evidence. Professional consensus in psychiatry has emphasized several open questions:

Long-term effectiveness and safety are not well established. Much of the published experience involves short courses — treatment periods under a month — followed by maintenance infusions whose schedules are determined empirically, patient by patient, rather than from long-term trial data. The benefit of each maintenance infusion should be weighed honestly against the uncertainties of longer-term exposure. In plain terms: the short-term picture is encouraging; the multi-year picture is still being written.

Cognitive effects over the long term need monitoring. Short-term, ketamine can transiently affect thinking and memory, and heavy recreational ketamine abuse is associated with lasting cognitive impairment across several domains. Studies of therapeutic ketamine for mood disorders have not shown cognitive decline — but those studies are small and short, so they can't fully rule out longer-term effects. This is why thoughtful programs include some periodic assessment of cognition for patients on ongoing ketamine, and why we take that seriously.

We can't reliably predict who will respond. There are only preliminary hints — some data suggest that slower processing speed or higher baseline anxiety might predict better response — but no dependable way to know in advance. This is part of why the initial infusions function as a test: response is assessed early, before committing to a longer course.

Drug interactions aren't fully mapped — and benzodiazepines may matter. Because of how ketamine is thought to work, medications that potentiate the GABA system — benzodiazepines such as lorazepam, alprazolam, clonazepam, and diazepam — may blunt its antidepressant effect. This is why we ask about these medications and give specific guidance before treatment. Do not stop or taper benzodiazepines on your own — that can be dangerous; manage it only with your prescribing physician.

Known risks

Ketamine is a medication anesthesiologists administer routinely and consider generally safe, but no medication is without risk. Recognized risks include transient increases in heart rate and blood pressure (with rare potential for cardiac events), dysphoria or anxiety during infusion, nausea, headache, dizziness, fatigue, vivid dreams or hallucinations during the session, bladder irritation (cystitis) and liver effects with repeated exposure, worsening of certain psychotic conditions, and — with misuse — a potential for abuse. Certain conditions make ketamine inadvisable, which is why every patient is screened beforehand. The full list of what to expect, and how we monitor and manage these, is on our Ketamine Infusion FAQ page.

How this shapes the way we practice

These uncertainties aren't reasons to avoid ketamine — they're reasons to do it carefully. In practice that means: honest expectations rather than miracle claims; treatment within an accredited medical facility with monitoring, by anesthesiologists experienced with the drug; a team approach in concert with your own psychiatrist, therapist, or primary care physician rather than in isolation; assessing response early instead of committing blindly to a long course; and attention to the questions above — cognition, interactions, and the limits of long-term data — as the field's evidence continues to evolve.

If you're weighing ketamine therapy and want a frank conversation about whether it fits your situation, call Newport Pain Management at (949) 759-8400. The right answer for you is one made with full information.

This page is for general education and is not a substitute for individual medical advice. Never start, stop, or change any prescribed medication without consulting your physician.